HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

Daily computer time bad for kids' maths and reading skills - and so is too much time playing with friends

Nama senior figures face questions today on sale of Northern Ireland loans

Seamus Heaney celebrated in new Derry cultural centre

'We all swore an oath to protect this country…It won't be abandoned', say gardaí as strike looms


Today's Stories

Busy Cork bridge to be surveyed after Japanese knotweed found

GSOC probe into Garda whistleblower’s complaint delayed two years over files

Fianna Fáil ‘has more positions on water than kama sutra’

Ombudsman faced delays when handling complaints relating to Tusla

Lifestyle

Space Week is an out of this world chance for families to experience the night sky

Wayfarers: A composition written as a response to the 1916 Rising

How to break up with dignity

Knights in shining armour: Irish full-contact medieval combat team set to showcase skills

More From The Irish Examiner